Bristol-Myers Squibb
Executive Summary
Maxipime I.V./IM "coming soon" ad published in Jan. 1 American Journal of Hospital Pharmacy. BMS filed an NDA for Maxipime (cefipime) 1g/2g in June 1992. Results from a Phase III cost- effectiveness study of the cephalosporin were discussed Dec. 5 at a symposium on antibiotics prior to the American Society of Hospital Pharmacists midyear clinical meeting ("The Pink Sheet" Dec. 13, 1993, p. 6)...